Scientific Temper

Biotechnology

From recombinant DNA to gene editing: cutting and pasting the code of life

Builds on: DNA as the code of life (DNA, RNA, reverse transcription) and Reading the genome (splicing).

In a nutshell

Manipulating the code of life has moved from cutting in the dark to writing with a pen. Recombinant DNA technology, from the 1970s, cuts a gene from one organism and pastes it into another, producing a transgenic organism; but it cannot choose exactly where to cut or paste. Gene editing, above all CRISPR-Cas9, reads the DNA sequence and cuts at the chosen spot, so it can delete or change a few letters without bringing in foreign DNA. India regulates the two differently.

  1. Recombinant DNA: scissors, glue and a carrier, copied from bacteria and viruses.
  2. Gene editing: a guide that finds the exact spot, and scissors that cut there.
  3. Beyond: base and prime editing, gene drives, synthetic biology.

Copy and paste whole genesEdit chosen lettersWrite new code

"India releases two genome-edited rice varieties"; "ICAR patents a home-grown gene-editing tool"

In May 2025 India released two rice varieties made by gene editing, and in September 2025 its agricultural research council obtained a patent on its own editing tool. Yet India permits the commercial cultivation of only one genetically modified crop, Bt cotton. Why are the new rice varieties not treated as GM crops, and why did India want its own editing tool?

So far we have been reading the code of life. Now we learn to change it. As before, the procedure matters only so far as it explains what each technique can and cannot do, and why the law treats them differently.

Two ways of changing the code

Recombinant DNA (rDNA) technologyGene editing (site-directed nucleases)
What it doesMoves a whole gene from one organism into anotherDeletes, changes or inserts letters at a chosen spot
PrecisionLow: cuts wherever the enzyme's target sequence occurs; the gene lands at an unpredictable placeHigh: a guide matches the exact sequence to be cut
ResultAlways transgenic: carries DNA from another speciesOften non-transgenic: only the organism's own DNA is changed
Usual name of cropsGM crops (e.g. Bt cotton)Genome-edited crops (e.g. the 2025 rice varieties)

How recombinant DNA technology was born

By the 1960s we understood DNA and the central dogma, and in principle knew that a gene from one organism could work in another, since all life uses the same four-letter code. What we lacked was a way to cut DNA at a chosen point and join pieces together. The tools came from watching a long war between bacteria and the viruses that attack them, the bacteriophages ("bacteria eaters").

  • Scissors: restriction enzymes. A phage injects its DNA into a bacterium, which then makes new phages. Bacteria defend themselves with restriction enzymes that cut foreign DNA. Each enzyme recognises a particular short sequence, usually four to eight letters long, and cuts wherever it occurs. ("Restriction" because they restrict the virus's growth.)
  • Glue: DNA ligase. An enzyme that joins cut pieces of DNA together.
  • Carrier: the vector. Bacteria carry, besides their main chromosome, small rings of DNA called plasmids, which copy themselves independently and can pass from one bacterium to another, even of a different kind. This horizontal gene transfer is a main route by which antibiotic resistance spreads among bacteria. Cut a plasmid open, insert a gene, close it with ligase, and the plasmid carries the gene into a bacterium.

In 1973 Stanley Cohen and Herbert Boyer used these tools to put a gene from one organism into a bacterium, where it worked. Genetic engineering had begun.

Making Golden Rice: the steps and their limits

Rice is a staple for millions but has no vitamin A in its grain. Vitamin A deficiency is a form of hidden hunger, a lack of micronutrients even when calories are enough, and it causes blindness and weakens immunity in children. Increasing the micronutrient content of a staple crop is biofortification. Daffodils and some bacteria have genes that make beta-carotene, which the body converts into vitamin A. The task was to move those genes into rice.

  1. Find the donor, an organism with the trait: here, the daffodil.
  2. Cut its DNA into pieces with restriction enzymes. We do not know which piece carries the gene, and the enzyme cuts wherever its sequence happens to occur.
  3. Insert the pieces into vectors and put them into bacteria, which multiply quickly. The collection of bacteria, each carrying a different piece, is a gene library.
  4. Screen and select the bacterium carrying the wanted gene: finding a needle in a haystack among thousands of pieces.
  5. Multiply it and insert the gene into the target, rice. For plants, a soil bacterium called Agrobacterium, which naturally transfers DNA into plants, is a common carrier; DNA-coated particles fired from a "gene gun" are another.
  6. The rice expresses the gene. Its grains make beta-carotene and are golden yellow: Golden Rice, first reported in 2000 (a later version used a maize gene). The Philippines approved it for commercial cultivation in 2021, the first country to do so, but in April 2024 a court revoked the biosafety permit, citing the lack of full scientific certainty about its effects; the appeal was still pending in late 2025.

One refinement matters. Genes from plants and animals contain introns, which bacteria cannot cut out. So to make a bacterium produce a human protein, scientists often start from the cell's mature mRNA, which has already been spliced, and turn it back into DNA with reverse transcriptase (see DNA as the code of life). This copied DNA, cDNA, contains only the coding sequence; a collection of such copies is a cDNA library.

The method's two weaknesses explain everything that followed: we cannot choose where to cut, and the new gene lands at an unpredictable place in the target's genome. Precision required a tool that could read the sequence.

What recombinant DNA made possible

  • Human insulin. Made in E. coli in 1978 and approved in 1982, it replaced insulin extracted from pigs and cattle; it was the first medicine made by genetic engineering.
  • Other proteins: human growth hormone, clotting factors for haemophilia, interferons, and monoclonal antibodies (see Therapeutics and vaccines).
  • Vaccines: the hepatitis B vaccine is a viral protein made in yeast. India's first recombinant vaccine, Shanvac-B for hepatitis B, came from Shantha Biotechnics, Hyderabad, in 1997.
  • Diagnostics for HIV, hepatitis and other infections, and industrial enzymes from engineered microbes.
  • GM crops such as Bt cotton (see GM and edited crops).

Gene editing: a torch and a pair of scissors

Gene editing uses site-directed nucleases (SDNs): enzymes that cut DNA (nucleases) at a site that we choose. Earlier versions, zinc-finger nucleases and TALENs, worked but had to be redesigned as a new protein for every target. CRISPR-Cas9, described in 2012 by Jennifer Doudna and Emmanuelle Charpentier (Nobel Prize in Chemistry, 2020), made editing cheap and quick.

CRISPR, too, was copied from bacteria. When a phage attacks, some bacteria store a short piece of the virus's DNA in their own genome, in a region of repeated sequences called CRISPR (clustered regularly interspaced short palindromic repeats). It is a memory of past infections. If the same virus returns, the bacterium makes an RNA copy of the stored piece, which guides an enzyme, Cas9, to the matching viral DNA, and Cas9 cuts it.

For editing, scientists write a guide RNA matching the target sequence. The guide RNA is the molecular torch: it finds the spot by pairing with matching letters. Cas9 is the molecular scissors: it cuts both strands there. RNA suits the guide's job because it breaks down after use. The cell then repairs the cut, and how it repairs decides the result.

DNA Cas9 guide RNA: matches the chosen letters both strands cut here a few letters lostSDN-1 letters corrected from a templateSDN-2 a whole gene insertedSDN-3
CRISPR-Cas9: the guide RNA finds the spot, Cas9 cuts, and the repair decides the edit.

CRISPR is precise, not perfect. Cas9 sometimes cuts at places whose sequence resembles the target (off-target effects), and repairs can be incomplete, so edited organisms must be checked.

SDN-1, SDN-2, SDN-3 and India's rules

TypeWhat is doneForeign DNA in the product?Status in India
SDN-1Cut and let the cell repair; a few letters are deleted or changed at random, usually switching the gene off ("knock-out")NoExempted since 2022 from the rules for GM organisms, if free of foreign DNA
SDN-2Cut and supply a short template, so the repair makes a planned change of one or a few lettersNo
SDN-3Cut and supply a long template carrying a whole gene, often from another speciesYes: transgenicRegulated as a GM organism

GM organisms in India are regulated under rules framed in 1989 under the Environment (Protection) Act, 1986, with approvals for environmental release by the Genetic Engineering Appraisal Committee (GEAC) (see GM and edited crops). In March 2022 the environment ministry exempted SDN-1 and SDN-2 genome-edited plants that contain no foreign DNA from these rules, and the Department of Biotechnology issued guidelines for assessing them. The reasoning was that such changes are like the mutations that arise naturally or in conventional breeding. Transgenic organisms remain regulated whichever technique made them, rDNA or SDN-3. This is why ICAR could release two genome-edited rice varieties in May 2025 (see GM and edited crops).

Sharper tools

  • Other Cas enzymes. Cas12 cuts DNA and Cas13 cuts RNA, so Cas13 can act after transcription without touching the genome. Both are used in quick diagnostic tests that detect a pathogen's DNA or RNA. India's FELUDA COVID-19 test, developed by CSIR-IGIB and named after Satyajit Ray's detective, used a Cas9 protein.
  • Base editing (2016) changes a single letter into another, for example C into T, chemically, without cutting both strands of the DNA. It suits diseases caused by a single wrong letter.
  • Prime editing (2019) nicks one strand and uses reverse transcriptase to write in a short new sequence: a "search and replace" that can make small insertions, deletions and any letter change.
  • TnpB. Most CRISPR patents are held abroad, and commercial licences are costly. Scientists at ICAR's Central Rice Research Institute, Cuttack, adapted TnpB, a small protein from the transposon "jumping gene" systems (see Reading the genome) that works like a compact Cas enzyme, to edit plant genes. ICAR received an Indian patent for it in September 2025. Being much smaller than Cas9, it is easier to deliver into cells.

Gene drives: editing a whole population

Normally an allele is passed to half of an organism's offspring. A gene drive is an edit that copies itself onto the partner chromosome, so it is inherited by nearly all offspring and spreads through a wild population within a few generations. In laboratory cages, gene drives targeting a gene called doublesex have wiped out populations of malaria-carrying mosquitoes. No country has yet approved an open release. The concerns are particular to this technology: once released, a drive is designed to spread across borders and ecosystems, and its effects on food chains are hard to predict or reverse. Self-limiting designs and staged, contained trials are being developed to address this.

A gene drive is easily confused with two other ways of using mosquitoes against the diseases they carry, and the three differ in what is released and what spreads. In the self-limiting approach, engineered males are released whose offspring do not survive to adulthood; the introduced trait disappears from the population unless releases continue, which is the point of the design. The Wolbachia approach involves no genetic engineering at all: Wolbachia is a bacterium found naturally inside the cells of many insects, though not of Aedes aegypti, and mosquitoes carrying it produce far less dengue virus and so transmit it poorly. The bacterium is introduced into mosquito eggs, the line is bred, and because Wolbachia passes from mother to offspring the infection spreads through the wild population by itself. ICMR's Vector Control Research Centre at Puducherry has developed Wolbachia-carrying Aedes aegypti lines with the World Mosquito Program for field evaluation in India.

ApproachWhat is releasedWhat spreads
Gene driveMosquitoes carrying an edit that copies itselfThe edit, to nearly all offspring; designed to spread and persist
Self-limiting engineered mosquitoesEngineered males whose offspring die before adulthoodNothing lasting; the effect fades unless releases are repeated
WolbachiaMosquitoes carrying a bacterium, not an engineered geneThe bacterium, passed from mother to offspring, blocking virus transmission

Synthetic biology: writing new code

Genetic engineering modifies what exists; synthetic biology designs and builds new biological parts, circuits and even genomes, treating cells as programmable factories. In 2010 the J. Craig Venter Institute put a fully synthetic genome into a bacterial cell, which then lived and divided; synthetic DNA alphabets such as Hachimoji (see Reading the genome) go further. Applications include microbes that make medicines, fuels, fragrances and biodegradable materials, which is why synthetic biology is central to plans for a bioeconomy. The same tools could in principle be misused to make harmful organisms, a dual-use concern; the Biological Weapons Convention (1972) bans biological weapons but has no system for verifying compliance.

Who owns a gene? Patents

A patent gives an inventor exclusive rights for a limited period, usually 20 years. India's Patents Act (Section 3(j)) does not allow patents on plants and animals, in whole or in part, including seeds, varieties and species, or on essentially biological processes for producing them; microorganisms, however, can be patented. New plant varieties are protected separately, with farmers' rights, under the Protection of Plant Varieties and Farmers' Rights Act, 2001 (see GM and edited crops). Courts elsewhere have drawn similar lines: in 2013 the US Supreme Court held that naturally occurring DNA cannot be patented, but man-made cDNA can.

From rDNA to editing at a glance

QuestionRecombinant DNACRISPR gene editing
Where did the tools come from?Bacteria's restriction enzymes; bacterial plasmids; viruses as carriersBacteria's CRISPR immune memory and Cas enzymes
How is the cut site chosen?By the enzyme's fixed recognition sequence, wherever it occursBy a guide RNA designed to match the chosen sequence
Typical productTransgenic organism; recombinant protein (insulin)Knock-out or corrected gene (SDN-1, SDN-2); insertion possible (SDN-3)
Main limitationImprecise; laborious screeningOff-target cuts; delivery into cells; patents

Recent developments

Indian patent for TnpB, a gene-editing protein a third the size of Cas9

ICAR announced in November 2025 that its Central Rice Research Institute at Cuttack had been granted a twenty-year Indian patent, 'Systems and Methods for Targeted Genome Editing in Plants', for editing with TnpB. TnpB is a transposon-associated nuclease of about 408 amino acids, roughly a third the size of Cas9 (1,000 to 1,400 amino acids) or Cas12a (about 1,300). The institute reports editing efficiency of up to 69 per cent in rice and in Arabidopsis, with multiplex editing and base editing also possible.

Why it matters: Size is the point. A smaller protein fits more easily into the viral vectors used to get editing machinery into a plant cell, which can avoid some of the tissue-culture steps that bulkier systems need. The second gain is legal rather than biological: TnpB is a different protein, so editing with it sits outside the Cas9 patents held abroad by the Broad Institute and by Corteva. For a country that wants to edit its own varieties and sell the seed, who owns the tool decides what a licence costs.

Remember: TnpB - ICAR-Central Rice Research Institute, Cuttack; twenty-year Indian patent reported in November 2025; about 408 amino acids, roughly one-third of Cas9; up to 69 per cent editing efficiency in rice (a monocot) and Arabidopsis (a dicot). A patent on a tool is not a released variety.

Source: ICAR, November 2025

BIRSA 101: an Indian gene-editing platform aimed at sickle cell disease

CSIR-IGIB launched BIRSA 101, described as India's first indigenous CRISPR-based gene therapy for sickle cell disease. It uses enFnCas9, an editing protein engineered at the institute rather than licensed from abroad: stem cells are taken from the patient, the gene is edited, and the cells are returned so that normal haemoglobin is produced. It was launched on 19 November 2025, named for the 150th birth anniversary of Birsa Munda, and a technology-transfer agreement was signed with Serum Institute of India for scale-up and trials.

Why it matters: Sickle cell disease is concentrated in tribal and central Indian districts, where the gene therapies approved abroad, priced at Rs 20 to 25 crore, are irrelevant in practice. An Indian editing protein matters for two separate reasons: it avoids the patent stack around Cas9, and it allows the cost of the whole procedure to be designed for Indian conditions. The platform is at the start of that road: a launch and a technology-transfer agreement are not an approved treatment, and the edited-stem-cell route still requires the demanding hospital procedure that goes with a bone-marrow transplant.

Remember: BIRSA 101 - CSIR-IGIB, launched 19 November 2025, named after Birsa Munda, aimed at sickle cell disease, built on the indigenous enFnCas9 protein, technology transferred to Serum Institute of India. Distinguish it from Casgevy, the CRISPR therapy approved abroad in 2023 for sickle cell disease and beta-thalassaemia. It supports the goal of a sickle-cell-free India by 2047.

Source: BioSpectrum India, November 2025

India releases its first two genome-edited rice varieties

The Union Agriculture Minister released two genome-edited rice varieties developed by ICAR on 4 May 2025 in New Delhi. DRR Dhan 100 (Kamala), from the Indian Institute of Rice Research at Hyderabad, was bred from Samba Mahsuri by editing a gene that limits grain number; it matures about 15 to 20 days earlier, at around 130 days, with a reported yield gain of roughly 19 to 25 per cent, and the shorter duration saves about three irrigations. Pusa DST Rice 1, from the Indian Agricultural Research Institute at New Delhi, was bred from MTU 1010 by editing the DST gene and is aimed at tolerance of salinity and alkalinity. Both used SDN-1 editing, in which the cell's own repair of a cut introduces the change and no foreign gene remains.

Why it matters: Here the regulatory distinction drawn in this chapter has a concrete consequence. Because SDN-1 and SDN-2 edited plants carrying no foreign DNA were exempted from the GM rules in 2022, these varieties could be released through the ordinary varietal channel, while GM mustard and Bt brinjal remain stalled. The claim to be first should also be stated carefully: India is the first country to release genome-edited varieties of rice, not the first to release a genome-edited crop. And a released variety is not yet a planted one; seed multiplication decides when farmers actually sow it.

Remember: DRR Dhan 100 (Kamala), from Samba Mahsuri - earlier maturity, more grains per panicle, three irrigations saved. Pusa DST Rice 1, from MTU 1010 - salinity and alkalinity tolerance. Both are SDN-1 edits carrying no foreign gene, which is why they fall outside the GM approval route. Released 4 May 2025.

Source: Prasar Bharati News Services, May 2025

Last-month notes
  • rDNA tools: restriction enzymes (bacterial defence against phages; cut at specific short sequences), DNA ligase (joins), vectors (plasmids, phages, viruses, yeast/bacterial artificial chromosomes; Agrobacterium for plants). First rDNA organism: Cohen and Boyer, 1973.
  • Plasmids spread antibiotic resistance by horizontal gene transfer.
  • Gene library; cDNA library (from mRNA by reverse transcriptase; no introns).
  • Golden Rice: beta-carotene genes from daffodil and a bacterium (later maize); Philippines approval 2021, halted by court 2024.
  • rDNA products: human insulin (1978; approved 1982), growth hormone, clotting factors, hepatitis B vaccine (India: Shanvac-B, 1997).
  • CRISPR = clustered regularly interspaced short palindromic repeats; guide RNA (torch) + Cas9 (scissors). Doudna and Charpentier, Nobel Chemistry 2020.
  • SDN-1 (delete), SDN-2 (small planned change), SDN-3 (insert gene, transgenic). India exempted SDN-1/2 without foreign DNA, March 2022.
  • Cas12 (DNA), Cas13 (RNA); FELUDA (CSIR-IGIB). Base editing (one letter, no double cut), prime editing (search and replace). TnpB: ICAR-CRRI, patent Sept 2025.
  • Gene drive: near-100% inheritance; no open release approved. Synthetic biology: synthetic genome cell, 2010.
  • Patents Act s. 3(j): no patents on plants, animals, seeds; microorganisms patentable.
  • Mosquito interventions: gene drive (edit copies itself, spreads); self-limiting engineered males (offspring do not survive); Wolbachia (bacterium, maternally transmitted, blocks dengue transmission; ICMR-VCRC Puducherry with the World Mosquito Program).

Statements to watch for

  • Restriction enzymes come from bacteria, not viruses.
  • A genome-edited crop is not necessarily transgenic; a GM crop made by rDNA always is.
  • India's exemption covers SDN-1 and SDN-2 only, and only without foreign DNA.
  • Cas13 targets RNA, not DNA.
  • Golden Rice makes beta-carotene (provitamin A), not vitamin A itself.
  • In CRISPR-Cas9, the RNA guides and the protein cuts.
  • Wolbachia mosquitoes are not genetically engineered: the bacterium is introduced and then passes from mother to offspring. A gene drive spreads an edit; self-limiting releases leave nothing behind.

Revise and apply

Activities to check your understanding, not new content. Answer first, then press Check or Show answers. Multiple-choice questions are original, in the UPSC style, not past UPSC questions. A printable workbook with all activities is on the theme page.

Complete the mind map

Type the missing words, then check.

From recombinant DNA to gene editing
rDNA toolkit
Scissors: enzymes
Glue: DNA
Small rings of bacterial DNA used as vectors:
CRISPR-Cas9
Finds the spot: guide
Cuts the DNA:
Kinds of edit
Delete letters:
Insert a whole gene:
Newer tools
Cuts RNA:
India's compact editor:
Fill in the blanks
  1. A collection of DNA copies made from mRNA, containing no introns, is a library.
  2. The soil bacterium commonly used to carry genes into plants is .
  3. Golden Rice makes , which the body converts into vitamin A.
  4. In India, GM organisms are regulated under rules framed under the Act, 1986.
  5. An edit designed to be inherited by nearly all offspring and spread through a wild population is a gene .
Match the tool to what it does
  1. Restriction enzyme
  2. Plasmid
  3. Base editor
  4. Prime editor
  5. Cas13
True or false? Correct the false ones
  1. Restriction enzymes were first obtained from bacteriophage viruses.
  2. All genome-edited crops are transgenic.
  3. In India, SDN-3 genome-edited plants are regulated like GM organisms.
  4. Plasmids can transfer antibiotic resistance between bacteria.
  5. Under India's Patents Act, seeds and plant varieties can be patented.
Decode the headline

"Genome-edited rice released; not subject to GM rules." (a) How can a crop be edited yet not count as GM? (b) What would have made it subject to GM rules?

UPSC-style question 1

With reference to the CRISPR-Cas9 system, consider the following statements:

  1. It was adapted from an immune mechanism that bacteria use against viruses.
  2. The guide RNA cuts the DNA, while Cas9 identifies the target sequence.
  3. It can be used to make edits that leave no foreign DNA in the organism.

Which of the statements given above are correct?

UPSC-style question 2

India's 2022 exemption of certain genome-edited plants from the rules for genetically engineered organisms applies to:

Write in about 50 words

Distinguish recombinant DNA technology from CRISPR-based gene editing. Answer in about 50 words.

0 words

The next question What has India actually done with these tools in its fields: why is Bt cotton the only GM crop grown, what happened to GM mustard, and how are genome-edited crops regulated?